- Q3 2026 revenue increased 158% YoY to $57.9M, achieving GAAP diluted EPS of $1.06 (non-GAAP EPS of $0.50).
- Adjusted EBITDA reached $28.5M (49% margin); cash and equivalents stood at $55.6M.
- Full-year 2026 revenue guidance raised from >$145M to >$175M.
Signal #151774 · SEC 8-K
$ETON SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $ETON filing catalyst
Why did $ETON trigger an AI stock catalyst alert?
$ETON triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +8.0/10). Headline: Eton Pharmaceuticals Reports 158% Q3 Revenue Growth, Raises FY26 Guidance to >$175M. Key points: - Q3 2026 revenue increased 158% YoY to $57.9M, achieving GAAP diluted EPS of $1.06 (non-GAAP EPS of $0.50). - Adjusted EBITDA reached $28.5M (49% margin); cash and equivalents stood at $55.6M. - Full-year 2026 revenue guidance raised from >$145M to >$175M.
How did $ETON stock react after the SEC filing?
After the SEC 8-K for $ETON, observed market reaction: T0 price $47.15. Past moves do not guarantee future results.
Where can I get real-time $ETON SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $ETON via Telegram and the VIP Web Terminal from €10/month.